D

Aclaris Therapeutics, Inc. ACRS

NASDAQ
Recommendation
Dividend Power Score
Day's Range
$3.40$3.55
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
My Lists My Alerts

09/30/2026 06/30/2026 03/31/2026 12/31/2025 09/30/2025
Net Income -18.51M -21.51M -19.82M -19.80M -14.61M
Total Depreciation and Amortization 100.00K 107.00K 102.00K 102.00K 110.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 2.42M 2.97M 3.20M 3.33M 2.96M
Change in Net Operating Assets -8.09M -1.42M -1.63M 3.24M 612.00K
Cash from Operations -24.08M -19.85M -18.15M -13.13M -10.93M
Capital Expenditure -13.00K -58.00K -13.00K -24.00K -23.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -33.21M 10.32M -30.92M 10.39M 13.85M
Cash from Investing -33.22M 10.26M -30.93M 10.37M 13.83M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 58.59M 114.00K 58.03M -- --
Repurchase of Common Stock -63.00K -23.00K -250.00K -162.00K 0.00
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -2.37M -3.04M
Cash from Financing 58.53M 91.00K 57.78M -2.53M -3.04M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 1.23M -9.49M 8.70M -5.30M -146.00K